Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on asymmetric catalytic hydrogenation. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN108863787A details efficient asymmetric hydrogenation for chiral alcohols. This report analyzes cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Novel asymmetric catalytic method for Eslicarbazepine production. Reduces operational cost and improves supply chain reliability for global pharmaceutical intermediates.
Novel patent CN115677771A offers efficient fosfomycin intermediate production with reduced costs and high purity for reliable pharmaceutical supply chains.
Patent CN112645854B details a novel purification method for Apremilast intermediates using PEG-modified catalysts and specific solvent systems to achieve over 99.5% purity.
Patent CN103214520B reveals ionic liquid supported chiral ligands enabling efficient catalyst recovery and high enantioselectivity for pharmaceutical intermediates manufacturing.
Novel patent CN112830879A details a cost-effective Cinacalcet Hydrochloride synthesis using m-trifluoromethyl benzaldehyde, offering significant supply chain and purity advantages.
Novel patent CN106810485A enables high-purity chiral biphenylpyrrolidone production. Eliminating protecting groups reduces waste and enhances supply chain reliability for global pharmaceutical partners.
Patent CN1179944C reveals advanced asymmetric hydrogenation for Levetiracetam. Enhances purity and supply chain reliability for pharmaceutical manufacturers globally.
Patent CN117567288A details a novel asymmetric hydrogenation process for chiral alcohols, offering significant cost reduction in pharmaceutical intermediates manufacturing and enhanced supply chain reliability.
Patent CN104892496A details a Rhodium-catalyzed asymmetric hydrogenation method offering high ee values and scalable production for pharmaceutical intermediates.
Patent CN110790708A details a novel iridium-catalyzed asymmetric hydrogenation route for Eslicarbazepine intermediates, offering high enantioselectivity and atom economy for pharmaceutical manufacturing.
Patent CN111825508A details asymmetric hydrogenation for high-purity chiral amines, offering cost-effective pharma intermediate manufacturing solutions.
Patent CN104892672B details a novel chiral spiro phosphine-nitrogen-sulfur ligand enabling high-efficiency asymmetric hydrogenation for cost-effective pharmaceutical intermediate manufacturing.
Novel Ru-phosphine-nitrogen complexes enable efficient ketone reduction. Enhances supply chain reliability and reduces manufacturing costs for chiral intermediates.
Patent CN105254474B enables high-yield chiral citronellol production via Rh-catalysis. Ideal for fragrance and pharma intermediates supply chain optimization.
Patent CN110627673B details a high-purity route for Formoterol intermediates using borane reduction, offering significant cost and supply chain advantages for API manufacturers.
Patent CN101121719A details a cost-effective route for (S)-4-ethyl-6,6-disubstituted alkoxy compounds, offering high stereoselectivity for anticancer drug manufacturing.
Patent CN103087105B details high-efficiency asymmetric hydrogenation for chiral beta-aryl amides, offering significant supply chain and cost advantages for pharmaceutical manufacturing.
Patent CN110655456B details Co-catalyzed hydrogenation of E/Z mixed olefins. Offers high ee and conversion for pharmaceutical intermediates.
Novel patent CN108822112A details high-yield tofacitinib synthesis. Offers cost reduction and supply chain reliability for pharmaceutical intermediate manufacturing.